| Price | $1.40 |
| Year Range | $1.27 – $5.32 |
| Market Cap | $6.6M |
| Industry | Biotechnology |
What Is Enveric Biosciences’s AI Stock Analysis?
Enveric Biosciences’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Enveric Biosciences’s momentum in near-real time.
Enveric Biosciences (ENVB) has an AltIndex AI Score of 42/100, currently a Hold signal. The AI Score distills Enveric Biosciences's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Enveric Biosciences’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Enveric Biosciences — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving ENVB’s AI Score?
Fundamentals
Net income for the last quarter was $-3M. This represents a decrease of 85.36% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 20.19%, which may be a cause for concern. Ebitda for the last quarter was $-3M. This represents a decrease of 87.39% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 20.63%, which may be a cause for concern.
See Enveric Biosciences’s earnings and insider transactions.
Technicals
Today's stock price is $1.40. This represents a decrease of 1.41% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 83.89%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $1.47, which is lower than the previous SMA10 of $1.48. This suggests a potential downward trend in price movement. The RSI is 37.3, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
The business outlook among employees at Enveric Biosciences is low (an estimate of only 0% of employees have a positive outlook), a concerning sign. Enveric Biosciences has an estimate of 2,000 visitors to their webpage, with no meaningful increase or decrese in the last couple of months.
Explore Enveric Biosciences’s job postings, web traffic and app downloads.
Sentiment & social
The sentiment for the stock on various stock forums is very high, a positive sign. Enveric Biosciences has 3,400 followers on their Twitter page. The number of followers is down by -1% in the last couple of months, indicating a loss in interest in the company.
Track Enveric Biosciences’s market sentiment.
Frequently Asked Questions: Enveric Biosciences AI Stock Analysis
Enveric Biosciences's AltIndex AI Score is 42/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Enveric Biosciences a Hold (42/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Enveric Biosciences — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ENVB AI Score or sign up to read the full thesis.
